- Home
- KBH vs ELAN Comparison
KBH vs ELAN Comparison
Compare KBH & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KBH
- ELAN
- Stock Information
- Founded
- KBH 1957
- ELAN 1954
- Country
- KBH United States
- ELAN United States
- Employees
- KBH N/A
- ELAN N/A
- Industry
- KBH Homebuilding
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- KBH Consumer Discretionary
- ELAN Health Care
- Exchange
- KBH Nasdaq
- ELAN Nasdaq
- Market Cap
- KBH 6.1B
- ELAN 6.3B
- IPO Year
- KBH 1987
- ELAN 2018
- Fundamental
- Price
- KBH $66.24
- ELAN $12.04
- Analyst Decision
- KBH Hold
- ELAN Buy
- Analyst Count
- KBH 13
- ELAN 7
- Target Price
- KBH $78.08
- ELAN $16.71
- AVG Volume (30 Days)
- KBH 1.1M
- ELAN 4.9M
- Earning Date
- KBH 01-09-2025
- ELAN 11-07-2024
- Dividend Yield
- KBH 1.51%
- ELAN N/A
- EPS Growth
- KBH 1.64
- ELAN N/A
- EPS
- KBH 7.79
- ELAN 0.41
- Revenue
- KBH $6,604,175,000.00
- ELAN $4,454,000,000.00
- Revenue This Year
- KBH $8.96
- ELAN $2.24
- Revenue Next Year
- KBH $6.39
- ELAN $2.79
- P/E Ratio
- KBH $8.50
- ELAN $29.20
- Revenue Growth
- KBH N/A
- ELAN 1.99
- 52 Week Low
- KBH $58.05
- ELAN $11.40
- 52 Week High
- KBH $89.70
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- KBH 24.52
- ELAN 42.36
- Support Level
- KBH $64.73
- ELAN $11.60
- Resistance Level
- KBH $67.07
- ELAN $12.19
- Average True Range (ATR)
- KBH 2.05
- ELAN 0.45
- MACD
- KBH -0.88
- ELAN -0.02
- Stochastic Oscillator
- KBH 9.66
- ELAN 34.84
About KBH KB Home
KB Home is an American construction company that focuses on residential construction in United States. The company builds single-family homes and communities across different geographical segments which include West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.